544 related articles for article (PubMed ID: 16124984)
1. Prognostic factors for long-term outcome after percutaneous thermal ablation for hepatocellular carcinoma: a survival analysis of 137 consecutive patients.
Xu HX; Lu MD; Xie XY; Yin XY; Kuang M; Chen JW; Xu ZF; Liu GJ
Clin Radiol; 2005 Sep; 60(9):1018-25. PubMed ID: 16124984
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC.
Toyoda H; Kumada T; Kaneoka Y; Osaki Y; Kimura T; Arimoto A; Oka H; Yamazaki O; Manabe T; Urano F; Chung H; Kudo M; Matsunaga T
J Hepatol; 2008 Aug; 49(2):223-32. PubMed ID: 18571271
[TBL] [Abstract][Full Text] [Related]
4. Selective prognostic impact of serum alpha-fetoprotein level in patients with hepatocellular carcinoma: analysis of 543 patients in a single center.
Huo TI; Huang YH; Lui WY; Wu JC; Lee PC; Chang FY; Lee SD
Oncol Rep; 2004 Feb; 11(2):543-50. PubMed ID: 14719097
[TBL] [Abstract][Full Text] [Related]
5. Serum alpha-fetoprotein response can predict prognosis in hepatocellular carcinoma patients undergoing radiofrequency ablation therapy.
Kao WY; Chiou YY; Hung HH; Su CW; Chou YH; Wu JC; Huo TI; Huang YH; Wu WC; Lin HC; Lee SD
Clin Radiol; 2012 May; 67(5):429-36. PubMed ID: 22153231
[TBL] [Abstract][Full Text] [Related]
6. [The factors related to the prognosis of solitary hepatocellular carcinoma after radiofrequency ablation].
Chung IK; Park MJ; Kwon KT; Park YD; Chung YJ; Jeon SW; Lee MK; Seo HE; Lee YD; Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH
Korean J Hepatol; 2005 Dec; 11(4):371-80. PubMed ID: 16380666
[TBL] [Abstract][Full Text] [Related]
7. Prognostic values of alpha-fetoprotein and protein induced by vitamin K absence or antagonist-II in hepatitis B virus-related hepatocellular carcinoma: a prospective study.
Kim HS; Park JW; Jang JS; Kim HJ; Shin WG; Kim KH; Lee JH; Kim HY; Jang MK
J Clin Gastroenterol; 2009; 43(5):482-8. PubMed ID: 19197197
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Minami Y; Ueshima K; Haji S
Oncology; 2007; 72 Suppl 1():98-103. PubMed ID: 18087189
[TBL] [Abstract][Full Text] [Related]
9. PIVKA-II is the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy.
Takahashi S; Kudo M; Chung H; Inoue T; Ishikawa E; Kitai S; Tatsumi C; Ueda T; Nagai T; Minami Y; Ueshima K
Oncology; 2008; 75 Suppl 1():91-8. PubMed ID: 19092277
[TBL] [Abstract][Full Text] [Related]
10. Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers.
Tateishi R; Shiina S; Yoshida H; Teratani T; Obi S; Yamashiki N; Yoshida H; Akamatsu M; Kawabe T; Omata M
Hepatology; 2006 Dec; 44(6):1518-27. PubMed ID: 17133456
[TBL] [Abstract][Full Text] [Related]
11. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis.
Hanazaki K; Kajikawa S; Koide N; Adachi W; Amano J
Am J Gastroenterol; 2001 Apr; 96(4):1243-50. PubMed ID: 11316177
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of tumor pressure as a prognostic factor in cases of hepatocellular carcinoma where the diameter of the tumor is 3 cm or less.
Ueki T; Sakaguchi S; Miyajima Y; Hatono N; Tohara K; Nakabayashi S; Yao T; Kokawa H; Hirano M; Okumura M
Cancer; 2002 Aug; 95(3):596-604. PubMed ID: 12209753
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
Fontana RJ; Hamidullah H; Nghiem H; Greenson JK; Hussain H; Marrero J; Rudich S; McClure LA; Arenas J
Liver Transpl; 2002 Dec; 8(12):1165-74. PubMed ID: 12474157
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous thermal ablation for recurrent hepatocellular carcinoma after hepatectomy.
Lu MD; Yin XY; Xie XY; Xu HX; Xu ZF; Liu GJ; Kuang M; Zheng YL
Br J Surg; 2005 Nov; 92(11):1393-8. PubMed ID: 16044409
[TBL] [Abstract][Full Text] [Related]
16. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center.
Ueno S; Tanabe G; Nuruki K; Oketani M; Komorizono Y; Hokotate H; Fukukura Y; Baba Y; Imamura Y; Aikou T
J Hepatobiliary Pancreat Surg; 2002; 9(4):469-77. PubMed ID: 12483269
[TBL] [Abstract][Full Text] [Related]
17. [Survival and prognostic analysis of radiofrequency ablation of hepatocellular carcinoma].
Yang W; Chen MH; Gao W; Wu W; Huo L; Dai WD; Liu WY; Yan K
Zhonghua Wai Ke Za Zhi; 2006 Feb; 44(3):169-73. PubMed ID: 16635345
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous radiofrequency ablation as first-line treatment for small hepatocellular carcinoma: results and prognostic factors on long-term follow up.
Waki K; Aikata H; Katamura Y; Kawaoka T; Takaki S; Hiramatsu A; Takahashi S; Toyota N; Ito K; Chayama K
J Gastroenterol Hepatol; 2010 Mar; 25(3):597-604. PubMed ID: 20074153
[TBL] [Abstract][Full Text] [Related]
19. High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies.
Poon RT; Lau C; Pang R; Ng KK; Yuen J; Fan ST
Ann Surg Oncol; 2007 Jun; 14(6):1835-45. PubMed ID: 17406950
[TBL] [Abstract][Full Text] [Related]
20. Treatment and prognostic factors in patients with hepatocellular carcinoma.
Martins A; Cortez-Pinto H; Marques-Vidal P; Mendes N; Silva S; Fatela N; Glória H; Marinho R; Távora I; Ramalho F; de Moura MC
Liver Int; 2006 Aug; 26(6):680-7. PubMed ID: 16842324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]